RecruitingNCT05301140

Vivistim Registry for Paired VNS Therapy (GRASP)


Sponsor

MicroTransponder Inc.

Enrollment

1,000 participants

Start Date

Mar 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.


Eligibility

Min Age: 22 Years

Inclusion Criteria1

  • Patients implanted with the Vivistim System for upper limb deficits associated with an ischemic stroke

Exclusion Criteria1

  • Not eligible for surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEVivistim System

VNS Paired with rehabilitation movements


Locations(2)

Mt. Sinai

New York, New York, United States

Thomas Jefferson

Philadelphia, Pennsylvania, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05301140


Related Trials